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Abstract 
 
During nervous system development, the cytoplasmic signaling protein MIG-10 activates cellular 
processes in response to guidance cues which ultimately lead to axonal growth and migration. 
Interactions between MIG-10 and two candidate downstream proteins, CSN-5 and ARX-3, were studied 
in vivo, using mutant transgenic C. elegans strains, and in vitro, using a co-immunoprecipitation system. 
Preliminary results indicate interaction in vitro between MIG-10 and both proteins. In vivo experiments 
are ongoing. 
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Introduction 
 
The nervous system is an amazingly intricate and complex organ system; not only 
physically, where the interlacing of nerves throughout a body creates a complex informational 
network, but also mechanistically, where many of the underlying processes of neuron growth and 
guidance are not yet well understood. Developmental neurobiology considers and examines both 
the molecular and cellular mechanisms which govern the growth and development of the nervous 
system during embryonic development, and throughout the life of any given animal (Yaron & 
Zheng, 2007).  
 
During development, billions of neurons can develop, each with a specific target and 
route of axon elongation.  Neurons rely on sensing attractive and repulsive guidance cues from 
their local extracellular environment with growth cones in order to travel the great distances 
necessary to make connections with the correct targets, and produce the wiring of a functional 
neuronal network (Letourneau, 2003). Failure to make correct and functional networks results in 
a dysfunctional nervous system, which could result in many neurodevelopmental disorders such 
as autism and Down’s syndrome. Understanding the processes responsible for neuronal 
connectivity would not only help elucidate the causes of neurodevelopmental disorders, but 
could also provide various new or improved treatment options for individuals with nerve damage 
due to injury such as a traumatic brain injury, or neurodegenerative disorders such as 
Alzheimer’s disease (Quinn & Wadsworth, 2008). 
 
Recently, there have been many discoveries concerning the extracellular component of neuron 
navigation. Many molecular guidance cues have been identified through biochemical 
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purifications, and many growth cone surface receptors which correspond to these molecules have 
been identified using genetic screens of vertebrates and invertebrates alike. Less is known about 
the internal, cytoplasmic signaling pathways that lead to the activation of cellular processes 
which lead to axonal growth and migration, and this MQP concerns some of the components of 
such a pathway (Yaron & Zheng, 2007; Quinn & Wadsworth, 2008).  
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Background 
 
C. elegans as a Genetic Model System 
Sydney Brenner first proposed Caenorhabditis elegans - a small, translucent nematode - 
as a genetic model system in the 1960s due to the worm’s small size and rapid lifecycle which 
made genetic manipulations simple. In 1998, C. elegans was the first multicellular organism to 
have its complete genome sequenced. Since then, a physical map of the genome has been 
produced with ever-improving annotations (Hillier, 2008). The nervous system of C. elegans is 
simple, stereotyped and is comprised of only 302 neurons of which nearly every axon and 
synapse has been mapped. This makes C. elegans an ideal organism to identify and characterize 
neurological defects, and the molecules that affect axon migration during development (Gabel, 
2008).  
 
Axon Guidance 
Axon guidance refers to the developmental process in which neurons rely on sensing 
attractive and repulsive guidance cues from their local extracellular environment in order to 
initiate axon elongation and make connections with the correct targets, producing the wiring of a 
functional neuronal network (Letourneau, 2003). Leading the outgrowth and guidance of 
neuronal axons is the growth cone, a highly motile structure at the tip of the axon which 
examines the extracellular environment and compiles the information gathered from guidance 
cues in order to make migratory decisions (Quinn, 2006) Several extracellular guidance 
biomolecules, such as netrin, slit, ephrin and semaphorin have already been identified as 
signaling molecules, which are conserved in both vertebrates and invertebrates (Yaron & Zheng, 
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2007). These ligands bind to receptors on the tip of the growth cone and elicit an intracellular 
signaling cascade which results in the initiation of cytoskeleton rearrangement in order to alter 
the direction of axon outgrowth. Specifically, there is an asymmetrical local accumulation of F-
actin and microtubule bundles in the filopodia, which are finger-like protrusions of the growth 
cone that extend beyond the lamellipodium as shown in figure 1 (Quinn, 2006). Unfortunately 
little is known about the cytoplasmic signaling pathways that regulate axon guidance. 
 
 
Figure 1. Schematic of Axonal Growth Cone (Lowery & Vactor, 2009). F-actin and microtubule bundles (red) 
are seen in the filopodia which are finger-like protrusions of the growth cone that extend beyond the lamellipodia-
like veil.  
 
A dynamic actin network is necessary for normal cell morphology, cytokinesis, 
locomotion, and for the outgrowth of filopodia. All of these cellular processes require the 
polymerization of actin monomers into filaments, and the bundling of those filaments under the 
control of actin-binding proteins (ABPs). ABPs cross-link filamentous actin into ordered bundles 
arranged in a parallel fashion. These actin bundles maintain the structural integrity of cells, 
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filopodia, and microvilli. Little is known about how cells initiate this dynamic assembly of actin 
in the right place at the right time during development, disease and injury (Zhang et al., 2009). 
 
MIG-10 and Its Role in the Proposed Actin Guidance Mechanism 
MIG-10, an ortholog of vertebrate lamellipodin, is a cytoplasmic signaling protein, 
belonging to the MRL protein family, which localizes in the filopodia of growth cones during 
axon guidance. A genetic screen for neuronal defects led to the discovery of several recessive 
mig-10 mutations, which result in abnormal neuronal migrations and severe excretory cell 
defects (truncation) (Manser and Wood, 1990; Manser et al., 1997). 
 
The excretory cell, which functions in osmoregulation, has a cell body which lies ventral to the 
posterior bulb of the pharynx and has parallel tubular processes which extend anteriorly and 
posteriorly from the cell body. Null mutations in mig-10 result in severe truncation of the 
excretory cell processes (Manser and Wood, 1990). The neurons investigated in this project are 
the Anterior Lateral Microtubule neurons (ALMs) and Anterior Ventral Microtubule neuron 
(AVM). The ALMs are known to migrate in an anterior to posterior direction to a location 
approximately half the length of the worm.  The AVM is known to send an axon, ventrally, to 
the nerve cord. Null mutations in mig-10 result in disruptions in the posterior migrations of the 
ALMs (Manser and Wood, 1990) and misguidance of the AVM axons (Quinn et al., 2006; 
Chang et al., 2006).  
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As with other MRL proteins, MIG-10 has several proline-rich regions, a Ras-interacting 
(RA) domain and a lipid-binding Plexstrin Homology (PH) domain. The PH domain has been 
shown to bind to PI(3,4)P2 (phosphotydyl inositol bisphosphate) and the RA domain has been 
shown to interact with CED-10/Rac GTPase for lamellipodin (Quinn, 2008). In addition, MRL 
family signaling proteins are known to interact with Ena/VASP proteins - most likely through 
proline-rich regions - which play a role in actin polymerization (Quinn et al., 2006). 
 
The proposed mechanism of axon migration mediated by MIG-10 is demonstrated by 
figure 2. This model supplies a possible sequence of events beginning with the activation of the 
UNC-40 transmembrane receptor by UNC-6 (netrin). This activates phosphoinositide 3-kinase 
(PI3K) and CED-10/Rac GTPase which in turn recruit MIG-10, resulting in its localization at the 
cell membrane. MIG-10 binds to the PI(3,4)P2 phospholipids and a Ras-related protein via its 
PH and RA domains, respectively (Quinn, 2006). The PI(3,4)P2 phospholipids were suggested to 
be phosphorylated by AGE-1, the C. elegans equivalent of PI3K, in a study in which a null 
mutant for AGE-1 resulted in suppression of  cell outgrowth in neurons overexpressing MIG-10 
(Chang et al., 2006). 
 
From here MIG-10 recruits complexes that in turn activate F-actin polymerization. The 
Ena/VASP protein UNC-34 is activated by binding to a proline-rich region on MIG-10 and is 
thought to interact with a complex which initiates actin anticapping and debranching. A 
WAVE/ABI-1 complex is also likely to be activated through an association with a proline-rich 
region of MIG-10, and it is thought that this complex may go on to activate the Arp2/3 complex 
which is responsible for F-actin polymerization (McShea, 2011). 
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Figure 2. Speculative Model for MIG-10 signaling cascade (Ficociello and Ryder 2007). In 
the presence of a guidance cue, the UNC-40 transmembrane receptor activates CED-10/Rac 
GTPase and PI3 kinase which in turn localizes MIG-10 and associated actin polymerization 
proteins to the cell membrane. 
 
Yeast Two Hybrid Screen Reveals More Potential Interactors of MIG-10 
 A yeast two hybrid library screen, using MIG-10A as bait, identified both ARX-3 and 
COP-9 as potential interactors of MIG-10 in the proposed signaling model. ARX-3 and COP-9 
were each independently isolated in 1 independent transformation of the C. elegans cDNA 
library. The same screen revealed ABI-1 as a potential interactor of MIG-10, and that interaction 
has since been confirmed through co-immunoprecipitation (Gossellin and O’Toole, 2008; 
McShea, 2011). 
 
ARX-3 
 ARp2/3 compleX component-3 (ARX-3) is one of seven subunits of the Arp2/3 complex, 
which nucleates and branches F-actin and caps the pointed ends of filaments forming y-branched 
actin networks (Letourneau, 2003). The mechanism of nucleation and branching is not well 
understood, but it is thought that the nucleation promoting factors (NPFs), responsible for 
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ARP2/3 activation are SCAR/WAVE proteins. The ARP2/3 complex is conserved in most 
eukaryotes, and the severity of the phenotypes that are a result of compromised ARP2/3 function 
demonstrates its important role in fundamental and conserved cellular processes including 
cellular migration (Disanza, et al., 2005). During cell migration, the ARP2/3 complex is 
localized to lamellipodia and pseudopodia within several micrometers of the leading edge, 
demonstrating that it may be a necessary component of cell migration, and perhaps growth cone 
elongation (Goley and Welch, 2006). It is interesting to note that a study proposed that UNC-
53/NAV2 may act as a scaffold that links ABI-1 (a confirmed member of the MIG-10 signaling 
pathway) to the ARP2/3 complex to regulate cytoskeleton remodeling (Schmidt et al., 2009). 
ARX-3 is an ortholog of the mammalian p41Arc subunit, and the p41Arc subunit is considered 
to be a putative regulatory component of the human ARP2/3 complex that may play an important 
regulatory role for the complex as a whole during actin remodeling (Welch et al., 1997). 
 
CSN-5 
 COP-9 SigNalosome Subunit-5 (CSN-5) is one of eight subunits of the COP-9 
SigNalosome which has been implicated in a wide variety of biological functions, yet its 
biochemical and physiological functions are only beginning to be understood (Wei and Deng, 
2003). The complex is conserved throughout eukaryotes, and has been found to be an integral 
part of the proper development of all multicellular organisms in which its function has been 
investigated. It has been suggested that COP-9 plays a key role in sustaining the activity of 
cullin-based ubiquintin ligases, which may explain its part in eukaryotic development (Cope and 
Deshaies, 2003; Miller et al., 2009) .  COP-9 may also regulate proteolysis through its 
association with protein kinases and deubiquitylating enzymes, which accounts for its role in 
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regulating protein degradation as well as in development (Schwechheimer, 2004). The CSN-5 
subunit of COP-9 (also known as Jab-1), specifically, is thought to interact with target proteins 
and has been implicated in numerous signaling pathways such as cell cycle control, integrin 
signaling and steroid hormone signaling, among other developmental pathways (Wei and Deng, 
2003; Chamovitz and Segal, 2001). 
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Project Goals 
  
 The overall goal for this Major Qualifying Project (MQP) was to determine whether 
ARX-3, an Arp2/3 subunit or CSN-5, a COP-9 SigNalosome subunit, interact with MIG-10 to 
promote axon outgrowth and migration. The MIG-10/subunit interactions were identified in a 
previous MQP using a yeast two hybrid system (Gossellin and O’Toole, 2008). Even though the 
results were confirmed by retransformation, the positive results could have been caused by self-
activation so the interactions need to be confirmed using entirely different systems. 
 
Project Goal A: Confirming the MIG-10/Subunit Interaction In Vivo 
 The first goal of this MQP was to confirm the in vivo interaction between MIG-10 and 
the two protein subunits (ARX-3 or CSN-5). Steps toward this goal were achieved by creating 
mutant transgenic C. elegans strains labeled with pgp-12::GFP which marks the excretory cell 
and with flp-20::GFP which marks the migratory neurons ALM and AVM. These strains are 
currently being quantitatively assessed. If the strains display truncation of the excretory canal or 
migratory neuron defects these phenotypes will constitute strong support for an in vivo 
interaction. 
 
Project Goal B: Confirming the MIG-10/Subunit Interaction In Vitro 
 The second goal of this MQP was to further confirm the MIG-10/subunit interaction that 
had been indicated in a previous MQP, this time in vitro. Co-immunoprecipitation (Co-IP) was 
chosen to be the biochemical system to further confirm the MIG-10/subunit interaction. In order 
to prepare this system the sequence of the constructs produced by the yeast two hybrid screen 
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were cloned into fusion-tagged insect vectors via the Gateway System©. Protein expression was 
achieved and a possible interaction was observed. 
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Materials and Methods  
Genetics 
 
Strain Maintenance 
All stock and mutant C.elegans strains used were maintained on Nematode Growth 
Medium (NGM) agar plates spotted with OP50 E. coli. Active strains were maintained twice 
weekly by transferring three L4 hermaphrodites of the correct phenotype to a new plate and were 
stored in a 20°C incubator. Inactive strains were maintained weekly in the same manner, and 
were stored in a 15°C incubator. Any starved plates were chunked and allowed to grow through 
several generations before use. Table 1 contains a list of maintained strains. 
 
Name Strain 
BC06288 sIs10089  (denoted pgp-12::GFP in this MQP) 
NY2053  ynIs54  (denoted flp-20::GFP in this MQP)   
N2M N2M 
VC3166 arx-3 (ok1122)/mT1[dyp-10(e128))]II;III 
VC861 csn-5 (ok1064)/nT1[gIs51]IV;V 
RY1162 arx-3 (ok1122)/ mT1[dyp-10(e128))]II;III; pgp-12::GFP    (Het) 
RY1160 csn-5 (ok1064)/ nT1[gIs51]IV;V; pgp-12::GFP    (Het) 
RY1163 arx-3 (ok1122)/ mT1[dyp-10(e128))]II;III; flp-20::GFP      (Het) 
RY1161 csn-5 (ok1064)/ nT1[gIs51]IV;V; flp-20::GFP      (Het) 
Table 1. C. elegans strains maintained during project. The first strain was provided by E. Stringham (UBC, 
Canada).  The next four strains listed were provided by the C. elegans Genetics Center (U Minnesota). The last four 
strains were designed by Meagan Sullender.  
 
Strain Design 
The mutant strains of C.elegans, RY1160, RY1161, RY1162 and RY1163, were 
generated through a series of crosses between a mutant strain containing the desired mutation 
and a transgenic marker strain. C.elegans strains RY1160 - RY1164 were crossed in parallel, and 
are summarized in figure 3. The first step consisted of crossing N2 males with L4 
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hermaphrodites containing the pgp-12::GFP or flp-20::GFP marker. The resultant offspring were 
homozygous for the pgp-12::GFP or flp-20::GFP marker. These male offspring were crossed 
with L4 hermaphrodites that were heterozygous for the csn-5 (ok1064) or arx-3 (ok1122) 
mutation for the RY1160/RY1161 and RY1162/RY1163 strains, respectively. The resultant male 
offspring were crossed back to their respective parent strain containing either the csn-5 (ok1064) 
or arx-3 (ok1122) mutation. Twelve of the resultant offspring were singled to separate plates and 
were self-crossed to determine whether worms carried the desired mutation. The plates that 
expressed the desired markers and phenotype were self-crossed again and checked until the final 
strains were obtained.  The RY1160 and RY1161 strains were considered a success when the 
strain appeared to be heterozygous for csn-5 (ok1064) and 100% homozygous for the marker. 
The RY1162 and RY1163 strains were considered to be a success when the strain appeared to 
possess the same lethality (measured by egg : worm ratio) as the parent arx-3 (ok1122) and 
100% homozygous for the marker. 
 
 
Figure 3: Summary of RY1160 – RY1163 Crosses. 
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Mutant Phenotype Quantitation 
Mutant C.elegans were washed from a plate using a glass pipette full of M9 buffer, and 
then swirling the plate so that the worms were washed from the surface of the plate and 
suspended into the buffer. The worm containing buffer was then pipetted into a 1.0 mL 
eppendorf tube, and the worms were allowed to settle to the bottom of the tube while the slides 
were prepared. Slides for quantitation were prepared by melting a 2.0 mL aliquot of agarose in a 
beaker of boiling water. Once the agarose was melted, 20 μl of 1M sodium azide was added, and 
one drop of this mixture was placed on a glass slide using a glass pipette. The drop was 
immediately covered with a second slide creating an agar pad between the slides. 5.0 μl of the 
worm containing buffer was added on top of the agar pad once it had solidified. A coverslip was 
immediately placed on top of the drop of worm containing buffer.  
 
The worm slide was then viewed under fluorescence at either 10x or 20x magnification 
(depending upon the worm) and a fluorescent and non-fluorescent photo was taken (using 
pixelfly) of each worm to be quantitated. The two photos were then superimposed and the length 
of the excretory canal (for pgp-12::GFP) or the ALM1 and 2 and AVM (for flp-20::GFP) was 
measured in pixels. Figure 4 shows where the measurements were taken and what reference 
points were used for each measurement.  
 
For pgp-12::GFP animals, the posterior process of the excretory canal (a) was measured 
from the middle of the cell body posterior, to the end of the canal. This was then compared to the 
length of the entire worm. The anterior process of the excretory canal (b) was measured from the 
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middle of the cell body anterior, to the “beginning” of the canal. This was then compared to the 
“nose” length of the worm, from the posterior of the pharynx to the “nose”.  
 
For flp-20::GFP animals, the AVM (c) was measured from the middle of the cell body 
posterior, to the middle of the vulva. This was then compared to the length of the worm between 
the posterior of the pharynx and the vulva (length PV). The ALM1 and 2 (d) were measured from 
the middle of the cell body posterior, to the middle of the vulva. This was then compared to the 
length of the worm between the posterior of the pharynx and the vulva (length PV). 
 
 
Figure 4. Sketches of Worm Quantitation. For pgp-12::GFP animals, the measurements of the posterior canal 
(a) and the anterior process of the excretory canal (b) were measured according to this schematic. For the flp-
20::GFP animals, the measurements of the AVM (c) and the ALM 1 and 2 (d) were measured according to this 
schematic. 
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Molecular Biology 
 
Vector Design 
The vector constructs to be used in the co-immunoprecipitation system were created 
using the Invitrogen Gateway cloning system, summarized in figure 5. PCR products were 
generated using 2.5 μl of 10X Thermopol buffer, 0.5 μl of dNTPs (stock concentration 10 mM in 
each dNTP), 1.0 unit of Vent polymerase (NEB), 5.0 pmol of each primer, and 3300 ng of C. 
elegans DNA library template. The primers shown in table 2 were designed in order to generate 
PCR products encoding the desired subunit (arx-3 or csn-5) of which the 5’ and 3’ ends were 
flanked by modified attB1 and B2 Gateway recombination sites, respectively. The annealing 
temperatures for csn-5 and arx-3 were 62
o
C and 64
o
C respectively. In order to confirm the 
presence of a PCR product of the appropriate size, 5-10% of the total volume of each PCR 
reaction was run on a 0.8% agarose gel in 1X TAE buffer.  
 
Primer Name 
 
Forward 
or Reverse 
Primer 
Generated 
Amplicon 
Length 
(bp) 
 
Sequence 
 
arx-3foratt 
 
 
Forward arx-3 56 
 
 
GGG GAC AAC TTT GTA CAA AAA 
 AGT TGG AAA ATG ACC AAC 
AGA ATC GTC TCA TGT TC 
arx-3revatt 
 
 
Reverse arx-3 49 
 
 
GGG GAC AAC TTT GTA CAA GAA  
AGT TGG GAC GAG TGA TGG GTG  
ATT CTT C 
arx-3_N_foratt 
 
 
Forward arx-3_C 60 
 
 
GGG GAC AAC TTT GTA CAA AAA  
AGT TGG AAA ATG TCG TCC GGC  
GTT CCC GTT CTC CAC TGG 
arx-3_C_revatt 
 
 
Reverse arx-3_C 60 
 
 
GGG GAC AAC TTT GTA CAA GAA  
AGT TGG GAC GAG TGA TGG GTG  
ATT CTT CAA ATC CCA AAG 
Table 2. Primers Used for Generation of AttB Flanked PCR Products. Primer names and sequences used to 
produce the indicated amplicons are shown. Top primer pair designed by Molly McShea and bottom primer pair 
designed by Meagan Sullender. Primers provided by IDT. 
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BP reactions were performed for each PCR product by mixing 150 ng of both pDONR 
vector and PCR product with 2.0 µl of BP Clonase II Enzyme mix (Invitrogen) and incubating 
the mixtures overnight at 25
o
C. The reactions were terminated the next day by incubation at 37
o
C 
and with the addition of 1.0 µl of Proteinase K. 5.0 µl of each reaction was then transformed into 
50 µl of Max-Efficiency DH5α E. coli chemically competent cells (Invitrogen). The cells were 
allowed to incubate on ice for 30 minutes, were heat shocked for 30 seconds at 47
o
C, and were 
incubated at 37
o
C on a nutator for 3 hours after the addition of 400 µl of SOC. The transformed 
cells were then plated on LB-agar plates containing 50 μg/mL kanamycin and incubated 
overnight at 37
o
C and colonies selected the next day were individually picked to 5.0 ml aliquots 
of liquid LB medium containing 50 μg/mL kanamycin. The liquid cultures were incubated 
overnight at 37
o
C. 0.5 ml of each culture was frozen down as a glycerol stock, and then the 
plasmid DNA of each sample was extracted via the QIAprep Spin Miniprep kit (Qiagen). 
Potential entry clones were screened by restriction digest using buffer 4 and 10 units Ban II 
(NEB) per 2 hour reaction at 37
o
C, and the identities of positively selected entry clones were 
confirmed by sequence analysis performed on A Plasmid Editor using sequencing data provided 
by GENEWIZ’s  Cambridge, MA facility. Samples were prepared for sequencing according to 
GENEWIZ’s pre-mixed guidelines. 
 
LR reactions were then performed for each BP product in order to insert the selected 
coding sequence into a vector suitable for transfection by mixing 150 ng of BP product with 150 
ng of either pUAST GFP or pUAST V5/6XHis (Duffy, WPI) with 2.0 µl of BP Clonase II 
Enzyme mix (Invitrogen) and incubating the mixtures overnight at 25
o
C. 5.0 µl of each reaction 
was then transformed into 50 µl of Max-Efficiency DH5α E. coli chemically competent cells 
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(Invitrogen) and were then plated on LB-agar plates containing 50 μg/mL ampicillin. The plates 
were incubated overnight at 37
o
C and colonies selected the next day were individually picked to 
5.0 ml aliquots of liquid LB medium containing 50 μg/mL ampicillin. Plasmid DNA was 
extracted via the QIAprep Spin Miniprep kit (Qiagen) as before, and the identities of the 
expression clones were confirmed by restriction digest using buffer 2 and 10 units Hind III 
(NEB) per 2 hour reaction at 37
o
C, followed by sequencing analysis. 
 
 
Figure 5. Gateway Cloning Strategy Summary. Each PCR product encoding the gene of interest was flanked with 
attB1 and attB2 sites. During the BP cloning reaction, these sites were recombined with attP sites in the donor 
vector, pDONR201. This produced a pDONR201 entry clone with an attL-flanked gene of interest. Any transformed 
cells possessing an unreacted donor vector were negatively selected by the lethal gene. During the LR cloning 
reaction, the attL sites of the pDONR201 Entry Clone were recombined with the attR sites of an expression vector 
containing a UAST element and a GFP or V5/6XHis tag. This produced expression vector with a hybrid attB-
flanked gene of interest. 
 
Mutant Genotype Confirmation 
The genotype of each mutant strain of C.elegans generated was confirmed via 10 worm 
PCR. Approximately ten worms were picked and added to a mixture of lysis buffer and 60 
 24 | P a g e  
 
μg/mL proteinase K enzyme in the cap of a PCR tube. The tubes were centrifuged and stored at -
80
o
C for a minimum of 30 minutes before proceeding to the lysis step. Lysis was performed by 
running the 10 worm tubes in the PCR machine under the lysis program (1 hour at 60
o
C, 15 
minutes at 95
o
C and 4
o
C forever). The lyses were then stored at -80
o
C for a minimum of 30 
minutes before proceeding to the PCR amplification step. The PCR step was performed by 
running the worm lysis tubes in the PCR machine under the short PCR program (10 minutes at 
94
o
C, 30 cycles with 1 minute at 94
o
C, 2 minutes at an annealing temperature of 55
o
C and 10 
minutes at 77
o
C and 4
o
C forever) after 16.5 µl of dH2O, 2.5 µl of 10X Thermopol buffer, 2.0 
units of  Vent polymerase (NEB) and 5.0 pmol of each primer were added to each tube of worm 
lysis. The primers shown in table 3 were designed in order to generate PCR products encoding 
the desired subunit (arx-3 or csn-5) from the lysed mutant strains. In order to confirm the 
presence of a PCR product of the appropriate size, 5-10% of the total volume of each PCR 
reaction was run on a 0.8% agarose gel in 1X TAE buffer. The mutations were further confirmed 
by sequence analysis performed on A Plasmid Editor using sequencing data provided by 
GENEWIZ’s Cambridge, MA facility. Samples were prepared for sequencing according to 
GENEWIZ’s pre-mixed guidelines. 
 
Strain Primer Primer Name Sequence 
VC3166 
(arx-3) 
External Left OK1122_external_for ctt gga aat cgt ttt ggc at 
External Right OK1122_external_rev tta aaa ctc cgg cca atc ag 
Internal Left OK1122_internal_for aac cac ttt tcc tcg tcc ct 
Internal Right OK1122_internal_rev ttt tcg tgg caa att cct tc 
VC3166 
Amplicons 
Wild type ...gatttttaatgttttcgatgt [1688 BP DELETION] gtttttgcggttaagccggtc… 
ok1122 ...gatttttaatgttttcgatgt ------------------ gtttttgcggttaagccggtc... 
VC861 
(csn-5) 
External Left OK1064_external_for cct gaa aca gtc acc aac ga 
External Right OK1064_external_rev cag act tcc cct tcc cag tt 
Internal Left OK1064_internal_for ttt tct tgc tca gct tgt gg 
Internal Right OK1064_internal_rev cag aaa aca ggg gga ctt ga 
 25 | P a g e  
 
VC861 
Amplicons 
Wild type ...tgagaattacttaatttgtt - [1030 BP DELETION] gcttgaaattttaaactttt... 
ok1064 ...tgagaattacttaatttgtt G------------------ gcttgaaattttaaactttt... 
Table 3. Primers Used for 10 Worm PCR. Primer names and sequences used to produce the indicated amplicons 
are shown. Primer pairs were designed by Meagan Sullender. Primers provided by IDT. 
 
Cell Culture and Protein Expression 
 
S3 Cell Culture Maintenance 
Cells from the D. melanogaster S3 line (Duffy, WPI) were maintained at room 
temperature in 1X Schneider’s medium (Gibco) supplemented with 12.5% FBS (Valley 
Biomedical). Cells were split when 80-90% confluent (every 3-4 days) using a 1:10 dilution. 
Following aseptic technique in the tissue culture hood, the old media was removed from the 
mother flask, and 4.5 mL and 5.0 mL of fresh media was added to the daughter and mother flask, 
respectively. The media in the mother flask was pipetted up and down 5-10 times, suspending 
the semi-adherent cells, and 0.5 mL of the suspension was added to the daughter flask. The 
media in the daughter flask was pipetted up and down 5-10 times, uniformly distributing the 
cells. 
 
Transfection 
In order to prepare cells for transfection, 2 mL of a 1:10 dilution of confluent cells was 
used to seed each well of one or more 6-well plates. When cells reached 80-90% confluence (2-3 
days post seeding), 133 ng of Arm-GAL4 (Duffy, WPI) and 133 ng of each of the appropriate 
expression constructs were co-transfected using the Effectene reagent kit and protocol (Qiagen). 
Cells were harvested 3-5 days post-transfection for use in either a practice western blot or the co-
immunoprecipitation system.  
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Biochemistry 
 
Western Blotting 
Transfections intended for practice western blotting were harvested by suspending and 
transferring 200 µl of cells from each well to correspondingly labeled 1.0 mL eppendorf tubes. 
The tubes were centrifuged at 8000 rpm for 5 minutes, the supernatant was removed and 20 µl of 
5X sample buffer, 80 µl of TBS and 1 µl of BME was added to each tube. These were frozen at -
20oC until use and were boiled for 5 minutes before being loaded into a gel. 
 
Gels were prepared by first sandwiching clean glass plates together, clamping them into a 
casting apparatus, and seal testing them for 5 minutes using dH2O. Meanwhile, the 10% 
separating gel solution was prepared in a 50 mL conical tube with 10% APS and TEMED added 
last. Working quickly, this solution was pipetted between the plates leaving about 3.0 cm of head 
space for the stacking gel, and the gel was immediately covered with 70% ethanol. After 40-60 
minutes, the ethanol was poured off and the stacking gel solution, made with 10% APS and 
TEMED added last, was quickly pipetted to the top of the plates. The comb was slowly inserted 
at an angle after the stacking gel was poured and was removed after the gel had polymerized, 20-
30 minutes later. 
 
The gel plates were removed from the casting apparatus and placed into the 
electrophoresis apparatus. The inner chamber was filled about half way with 1X electrophoresis 
buffer, and the wells were rinsed several times by pipetting electrophoresis buffer into each well. 
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Then, the inner chamber was filled with additional buffer to cover the wells, and the outer 
chamber was filled to cover the bottom of the gels. 5.0 µl Fisher EZ-Run Pre-stained Rec Protein 
Ladder and prepared samples (from -20
o
C freezer) were pipetted neatly into wells. The gels were 
run at 20mA (constant current) for 2-2.5 hours. 
 
In preparation for protein transfer, one corner of a nitrocellulose/ECL membrane (GE 
Healthcare) was notched and transferred with tweezers into 1X transfer buffer to soak for 15-20 
minutes. Fiber pads and Whatman paper were also allowed to soak in 1X transfer buffer in the 
transfer apparatus for 15-20 minutes. The stacking gel and a corner notch of the separating gel 
were cut off, and the gel was removed from between the glass plates and soaked in 1X transfer 
buffer in a tip box for 5 minutes. A transfer “sandwich” was then made by placing a fiber pad 
and a piece of Whatman paper on the black side of a cassette. The gel was carefully laid on the 
paper, and the membrane was placed over the gel (matching notched corners). The remaining 
Whatman paper and fiber pad were added over the membrane being careful to remove any air 
bubbles. Transfer “sandwiches” were then placed into the transfer apparatus (filled with 1X 
transfer buffer), matching black sides. An ice pack was placed into the transfer tank, and the 
transfer was run for 1 hour at 100V (constant voltage).  Ladder bands appeared on membrane 
when transfer was complete. To confirm protein transfer, the membrane was stained with 
Ponceau for about 5 minutes, and the membranes were rinsed with dH2O until bands were 
visible. 
 
Immunoblotting began with blocking the nitrocellulose membrane in 20-25mL 5% 
NFDM in TBST at RT for 30 minutes to 1 hour. The membrane was then rinsed with TBST to 
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remove excess blocking solution, then incubated in 10 mL of the appropriate primary antibody 
diluted in TBST+NFDM overnight at 4C. Invitrogen mouse monoclonal anti-V5 antibody - 
diluted 1:5,000 in 1% NFDM in TBST – was used for detection of V5-tagged proteins. Clontech 
mouse monoclonal anti-GFP antibody (JL-8) - diluted 1:1,000 in 0.5% NFDM in TBST – was 
used for detection of GFP-tagged proteins. The membrane was washed 5 times with 20-25 mL 
TBST - 5 minutes each wash - after the overnight incubation. The membrane was then incubated 
with a secondary antibody, Jackson ImmunoResearch Labs HRP conjugated goat anti-mouse - 
diluted 1:20,000 in 5% NFDM in TBST, for 1 hour at room temperature. The membrane was 
washed 5 times with 20-25 mL TBST - 5 minutes each wash - after the hour long incubation. 
During the final wash, 1.5 mL of the substrate working solution ( 1:1 peroxide:luminol solutions) 
was made for the gel. After the final wash, the membrane was removed with tweezers, dried 
slightly on a Kimwipe and placed on plastic wrap. The substrate working solution was applied 
uniformly to the membrane in a drop-wise fashion, and was allowed to incubate for 5 to 10 
minutes. The membrane was then picked up, dried slightly on a Kimwipe, and placed inside a 
sheet protector in an autoradiography cassette. 
 
The cassette was brought to the darkroom, and (under red light) one piece of film was 
placed in the cassette over the membrane and the cassette was closed. Exposure times varied 
between 30 seconds and 3 minutes. After exposure, the film was fed into the X-omat to develop; 
when it beeped, the lights were turned back on. The ladder bands and the 72 Da band label were 
drawn on after the film was developed. 
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Co-Immunoprecipitation (Protein A and His-tagged Magnetic Beads) 
For the whole cell lysate (WCL) samples, 200 µl of each well was set aside in a labeled 
1.0 mL eppendorf tube. This WCL sample was centrifuged at 8000 rpm for 5 minutes, and the 
supernatant was poured off. The pellet was resuspended using 100 µl of 1X sample buffer, and 
the sample was set aside at 4
o
C until use.  
 
For the immunoprecipitation samples, the remaining cells in each well were transferred to 
a 15 mL conical, and were pelleted at 2000rpm for 2 minutes at 4
o
C, and the supernatant was 
poured off. These cells were lysed in 1.0 mL of ice cold EBC buffer, 2X protease inhibitors and 
1X phosphatase inhibitors. Each conical was vortexed in order to completely resuspend the 
pellets. These lysates were left on ice for 15 minutes to complete the lysis. These lysates were 
then transferred to labeled 1.0 mL eppendorf tubes, and the insoluble fraction was pelleted at 
14,000 rpm for 10 minutes at 4
o
C. Meanwhile, the water block was preheated to 95
o
C and 2X 
sample buffer (90 µl per column to be used) was heated.  
 
The supernatant from each pelleted IP lysate (not WCL!) was transferred to fresh, labeled 
1.0 mL eppindorf tubes and the antibody of choice was added to the samples. 2.0 µl of anti-GFP 
(Rabbit polyclonal from Clontech) was used per tube reaction.  These samples were rotated for 
30 minutes (min) to 2 hours (max). 100 µl of Protein A magnetic beads were added to each 
sample and the sample-bead mixes were incubated on a rotator for 30 minutes (min) to 2 hours 
(max) or even overnight.  
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Columns were placed onto the magnetic board with a waste container underneath, and 
each column was rinsed once with 200 µl of Lysis Buffer (EBC+ inhibitors). The cell lysates (for 
IP, not WCL) were applied to the columns, and were allowed to run through. The flow through 
was saved in labeled 1.0 mL eppindorf tubes in case the IP did not work. New waste tubes were 
then used when the columns were rinsed with 200ul of Lysis Buffer 4X, 100ul of Buffer X and 
then 100ul of Final Wash Buffer. 
 
Fresh, labeled 1.0 mL eppindorf tubes were used for collection. Elution was performed 
by applying 20 µl of preheated 2X sample buffer to each column, and incubating for 5 minutes at 
room temperature. An additional 50 µl of preheated 2X sample buffer was added to each column, 
and the liquid elution was collected. The IP and WCL samples were boiled at 100
o
C for 5 
minutes, and loaded onto a western gel.  
 
 
Figure 6: Co-Immunoprecipitation Strategy. DNA constructs were transfected into D. melanogaster S3 cells in 
order to produce proteins of interest. The GFP-tagged protein would be “pulled down” by the protein A magnetic 
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beads via the  PC GFP antibody, and the V5-tagged protein would be “pulled down” by the GFP-tagged protein if 
there is an interaction. The co-immunoprecipitates were then run on a western blot and probed using anti-GFP or 
anti-V5 antibodies to detect the GFP or V5-tagged proteins respectively 
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Results  
 
Interactions between MIG-10 and two candidate downstream proteins, CSN-5 and ARX-
3, were studied in vitro, using a co-immunoprecipitation system, and in vivo, using mutant 
transgenic C. elegans strains. Expression clones containing the sequence of the ARX-3 and 
CSN-5 proteins were generated for use in an insect cell co-immunoprecipitation system, and 
western blots were performed in order to probe co-immunoprecipitates for proteins of interest. 
Mutant transgenic C. elegans strains were generated in order to quantitate the excretory canal 
and migratory neuron truncation phenotypes of worms possessing either arx-3 (ok1122) or csn-5 
(ok1064) mutation. 
 
Expression Clones Used in the CO-IP System 
Full-length Att flanked arx-3 was generated by PCR from C. elegans library DNA stock 
using forward and reverse primers. During the BP cloning reaction, Att sites were recombined 
producing an entry clone containing full-length arx-3. The entry clone DNA was transformed 
into E. coli which was then plated and colonies were cultured in liquid media and plasmid DNA 
was extracted via Miniprep. Miniprep DNA was then digested with BanII and run on an 
electrophoresis gel (Figure 7.). 
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Figure 7. Electrophoresis Gel of Digested Entry Clones. Entry clones generated via BP Clonase reaction were 
digested with BanII and run on a 0.8% agarose electrophoresis gel.  
 
This gel shows a partial digest of candidate entry clones; DNA corresponding to lanes 2, 
4, 5 and 7 had bands of the appropriate size, and therefore underwent sequencing analysis. The 
clone from lane 2 (entry clone 7a) exhibited the correct sequence, highest DNA concentration 
and least protein contamination, so a sample of the E. coli culture for entry clone 7a was frozen 
down (1:1 ratio of E. coli culture to 50% glycerol) into the -80oC glycerol stocks for future use.  
 
The DNA from entry clone 7a was used in order to generate expression clones tagged 
with GFP. During the LR cloning reaction, Att sites were recombined producing an expression 
clone containing full-length arx-3. The expression clone DNA was transformed into E. coli 
which was then plated and colonies were cultured in liquid media and plasmid DNA was 
extracted via Miniprep. Miniprep DNA was then digested with HindIII and run on an 
electrophoresis gel. This cloning step was repeated four times where E. coli yielded no plasmid 
DNA.  
  1 2 3 4 5 6 7 8 9 10 
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An antibiotic dosage experiment where liquid cultures were grown in media 
supplemented with 1.0 µg/mL, 2.0 µg/mL or 4.0 µg/mL ampicillin was performed in order to 
investigate the possibility of weak selection for the growth of only arx-3
+
 E. coli. Two cultures 
(at 2.0 µl/mL ampicillin) exhibited growth, and plasmid DNA was extracted via Miniprep after 
less than 12 hours of incubation. The Miniprep DNA was run on an electrophoresis gel before a 
restriction digest was attempted (Figure 8.). 
 
Figure 8. Electrophoresis Gel of Undigested Expression Clones. Entry clones generated via LR Clonase reaction 
via an antibiotic dosage experiment were run on a 0.8% agarose electrophoresis gel.  
 
This gel shows uncut candidate expression clones generated from the antibiotic dosage 
experiment. DNA corresponding to lanes 6 and 7 had bands of the appropriate size, and were 
therefore digested with HindIII and run on an electrophoresis gel (Figure 9.). 
1 2 3 4 5 6 7 8 9 10 
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Figure 9. Electrophoresis Gel of Digested Expression Clones. Entry clones generated via LR Clonase reaction 
were digested with HindIII and run on a 0.8% agarose electrophoresis gel.  
 
This gel shows a complete digest of expression clones generated from the antibiotic 
dosage experiment; DNA corresponding to lanes 5 and 7 had bands of the appropriate size, and 
therefore underwent sequence analysis. The clones from both lanes 5 and 7 (expression clone 1 
and 2) exhibited the correct sequence, high DNA concentration and low protein contamination, 
so  samples of the E. coli culture for expression clones 1 and 2 were frozen down (1:1 ratio of E. 
coli culture to 50% glycerol) into the -80oC glycerol stocks for future use. Entry clone 1 was 
selected for use in transfections. This GFP-tagged full-length arx-3 plasmid was then ready for 
use in the insect cell co-immunoprecipitation system along with the csn-5 and partial-length arx-
3 GFP-tagged plasmids which were generated in the summer of 2011 by Meagan Sullender. 
 
Do Candidate Proteins Interact with MIG-10 In Vitro? 
The MIG-10/subunit (ARX-3 and CSN-5) interaction was identified using a yeast two 
hybrid system (Gossellin and O’Toole, 2008) in a previous MQP. Even though the results were 
confirmed by retransformation, the positive results could have been caused by self-activation so 
1 2 3 4   5 6 7 8 9 10 
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the interaction needed to be confirmed using an entirely different system. Co-
immunoprecipitation (Co-IP) was chosen to be the biochemical system to further confirm the 
MIG-10/subunit interaction. The plasmids containing GFP-tagged csn-5 and arx-3, which were 
created via the Gateway System©, were used in this Co-IP system.  
 
Simple western blots were performed initially, in order to assess the transfection 
efficiency of the plasmids and stability of the expressed proteins. The plasmids containing GFP-
tagged csn-5 and arx-3 (one construct per well) were co-transfected into nearly confluent D. 
melanogaster S3 cells along with Arm::Gal-4 using an effectine based technique resulting in 
protein expression in about 10% of the cells three to five days after transfection (Figure 10). 
Cells were harvested on day four post transfection, run on an acrylamide gel, and probed with 
monoclonal anti-GFP antibodies (JL-8) to detect the GFP-tagged proteins. The blots (results not 
shown) showed good protein expression, so co-transfection of plasmids for the co-
immunoprecipitation system began. 
 
 
Figure 10. Transfected S3 Cells Expressing GFP-tagged Proteins. . The plasmids containing GFP-tagged csn-5 
and arx-3 (one construct per well) were co-transfected into nearly confluent D. melanogaster S3 cells along with 
Arm::Gal-4 using an effectine based technique resulting in protein expression in about 10% of the cells three to five 
days after transfection. This photo was taken on day 3 post-transfection (“single” construct transfection), and this 
GFP expression level was considered to be the minimum level acceptable to later run a Co-IP from a co-transfection. 
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Generation of samples for use in the Co-IP system began when the plasmids containing 
GFP-tagged csn-5 and arx-3 (one construct per well) were co-transfected singly and with mig-
10a::V5 into nearly confluent D. melanogaster S3 cells along with Arm::Gal-4. In addition, 
GFP-tagged abi-1 WT and mutant abi-1 were co-transfected with mig-10a::V5 and were used as 
positive and negative controls respectively. Cells were harvested on day four post transfection, 
run through the Co-IP system, run on an acrylamide gel, and probed with monoclonal anti-GFP 
antibodies (JL-8) to detect the GFP-tagged proteins (CSN-5, ARX-3, ABI-1 WT and ABI-1 
Mutant) and monoclonal anti-V5 antibodies to detect V5-tagged MIG-10. 
 
Initial Co-IP experiments yielded minimal protein expression, and what small protein 
concentration was present in the samples, was reduced even more when the samples were run 
through the Co-IP system.  
 
A plasmid DNA concentration experiment was performed in order to investigate as to 
whether plasmid DNA concentration could influence the concentration of expressed proteins. 
The plasmid DNA concentrations were adjusted for transfection as follows; a “control” 
transfection was performed with the usual 2:2:2 ratio (2.0 µl of 66.6 ng/ µl DNA per plasmid) of 
Arm::Gal4 to MIG-10::V5 to ARX-3::GFP, then four experimental transfections were performed 
with a 4:2:2 ratio, a 4:4:2 ratio, a 4:2:4 ratio, and a 4:4:4 ratio. The transfections performed with 
the 4:2:2 and 4:2:4 ratios demonstrated significantly brighter fluorescence than any of the other 
transfections, and were therefore run through the Co-IP system along with the 2:2:2 ratio 
“control” transfection and appropriate Co-IP controls. The samples were then run on an 
acrylamide gel, and the blots were probed with anti-GFP and anti-V5 antibodies. The 4:2:2 ratio 
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proved to produce higher apparent protein concentrations (bands in lanes 2 and 9 were broader 
and darker than those in lane 8) and produced a positive result (see Figure 12), so this ratio was 
used in all future transfections rather than the previously used 2:2:2 ratio. 
 
Figure 11. Blot of ARX-3 and MIG-10 Co-Immunoprecipitate. Constructs were transfected as shown in the 
table.  Cell lysates were immunoprecipitated with anti-GFP antibody, and immunoblotted with either an anti-V5 
antibody (MIG-10 constructs) or and anti-GFP antibody (ARX-3 or ABI-1 constructs).  Molecular weight markers 
are shown.  Yellow arrow shows MIG-10::GFP at 79 kDa; blue arrow shows ARX-3::GFP at 64 kDa and  red arrow 
shows Co-IP background band at about 50 kDa. 
 
This figure shows that there is an interaction between MIG-10 and ARX-3 in the co-
immunoprecipitation system. The anti-GFP blot (bottom) showed the presence of ARX-3 in lane 
2 (blue arrow) with a band of the appropriate size, while the anti-V5 blot (top) showed the 
presence of MIG-10 (boxed) with a band of the appropriate size. This result shows that MIG-10 
was indeed pulled down by ARX-3 indicating an in vitro interaction between the two proteins. 
WCL (lanes 8 and 9) samples showed the presence of ARX-3 when probed with anti-GFP and 
the presence of MIG-10 when probed with anti-V5. The positive (ABI-1 WT) and negative 
(ABI-1 Mutant) controls (lanes 6 and 7) in this experiment showed that co-immunoprecipitation 
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was possible, and that the pull down was not random or nonspecific, respectively. Also, all Co-IP 
lanes contained a background band (red arrow).  Previous work has shown that this band is due 
to reaction of the antibodies with Protein A sepharose (McShea, 2011). 
 
Figure 12. Blot of CSN-5 and MIG-10 Co-Immunoprecipitate. Constructs were transfected as shown in the table 
according to the 4:2:2 DNA ratio described in the text.  Cell lysates were immunoprecipitated with anti-GFP 
antibody, and immunoblotted with either an anti-V5 antibody (MIG-10 constructs) or and anti-GFP antibody (ARX-
3 or ABI-1 constructs).  Molecular weight markers are shown.  Yellow arrow shows MIG-10::GFP at 79 kDa; blue 
arrow shows ARX-3::GFP at 70 kDa and  red arrow shows Co-IP background band at about 50 kDa. 
 
This figure suggests that there may be an interaction between MIG-10 and CSN-5 in the 
co-immunoprecipitation system. The anti-GFP blot (bottom) showed the presence of CSN-5 in 
lane 1-3 with bands of the appropriate size (blue arrow), while the anti-V5 blot (top) showed the 
presence of MIG-10 (boxed) in lane 2 with a faint band of the appropriate size. This result shows 
that MIG-10 was indeed pulled down by CSN-5 indicating an in vitro interaction between the 
two proteins. WCL of the lane 2 sample (lane 9) showed the presence of CSN-5 when probed 
with anti-GFP and the presence of MIG-10 when probed with anti-V5. As for the previous 
experiment, the positive (ABI-1 WT) and negative (ABI-1 Mutant) controls (lanes 5 and 6) in 
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this experiment showed that the pull down was not random or unspecific. Also, all Co-IP lanes 
contained a background band (red arrow). 
 
With these two positive results, it can be said that preliminary results from the co-
immunoprecipitation system suggest that there may indeed be an interaction between MIG-10 
and the candidate proteins, ARX-3 and CSN-5. 
 
Do Candidate Proteins Interact with MIG-10 In Vivo? (Ongoing) 
Confirming the in vivo interaction between MIG-10 and the two protein subunits (ARX-3 
or CSN-5) was achieved by creating mutant transgenic C. elegans strains labeled with pgp-
12::GFP which marks the excretory cell and with flp-20::GFP which marks the migratory 
neurons ALM and AVM. This was done in order to quantitate the excretory canal and migratory 
neuron truncation phenotypes of worms possessing either arx-3 (ok1122) or csn-5 (ok1064) 
mutation. 
 
After the last crossing step, L4 hermaphrodites were picked to single plates in order to 
determine the homogeneity. The desired strain demonstrated a homozygous pgp-12::GFP marker 
genotype (100% fluorescent excretory canal phenotype across worms) and a heterogeneous csn-5 
(ok1064) or arx-3 (ok1122) with balancer genotype (determined by vulval mass or survival rate 
phenotype across worms, respectively). Table 4 shows the singled L4s and the egg/worm counts 
to objectively determine survival rates for the arx-3 worms. The plates of csn-5 worms were 
scanned for the vulval masses, but were not counted. 
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Strain/Cross Name Plate 
Number 
Eggs? Egg 
Count 
Worm 
Count 
Percent 
Worms 
pgp-12;csn-5 X self      (Progeny) 1 YES x X   
pgp-12;csn-5 X self      (Progeny) 2 YES x X   
pgp-12;csn-5 X self      (Progeny) 3 YES x X   
pgp-12;csn-5 X self      (Progeny) 4* YES x X   
pgp-12;csn-5 X self      (Progeny) 5 YES x X   
      
pgp-12;arx-3 X self      (Progeny) 1 YES 78 0 0% 
pgp-12;arx-3 X self      (Progeny) 2 YES 68 29 43% 
pgp-12;arx-3 X self      (Progeny) 4 No**       
pgp-12;arx-3 X self      (Progeny) 5 YES 46 19 41% 
pgp-12;arx-3 X self      (Progeny) 9 YES 46 20 43% 
pgp-12;arx-3 X self      (Progeny) 10* YES 79 12 15% 
pgp-12;arx-3 X self      (Progeny) 12 YES 60 26 43% 
      
csn-5 (Parent Strain) 1 YES x X   
csn-5 (Parent Strain) 2 YES x X   
arx-3 (Parent Strain) 1 YES 40 12 30% 
arx-3 (Parent Strain) 2 YES 78 19 24% 
Table 4. Strain Verification Experiment for C. elegans Strains Possessing Marked Excretory Cells. *These 
plates were used in quantitation experiments. **This arx-3 worm appeared to be an “escaper” as it grew to maturity, 
but was sterile. The ‘Strain/Cross Name’ column is not the real genotype of the strain, but rather a shorthand for the 
mutant/balancer strain produced. 
 
This table shows the singled L4s and the egg/worm counts to objectively determine 
survival rates for the arx-3 worms (RY 1162). The plates of csn-5 worms (RY 1160) were 
scanned for vulval masses, but were not counted. The plate numbers marked with an asterisk 
were believed to be the sought after strains and were maintained and used in quantitation 
experiments. The csn-5 plate chosen had the most obvious and highest incidence of worms 
exhibiting vulval masses (subjective determination) because this is the phenotype of worms 
homozygous for csn-5 (ok 1064). The arx-3 plate chosen had the lowest survival rate, which 
most closely resembled that of the parent strain, where worms homozygous for arx-3 (ok 1122) 
are thought to die early in development due to the “lethality” of the arx-3 (ok 1122) mutation. 
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The “No” marked with a double asterisk was believed to be an arx-3 worm which appeared to be 
an “escaper” as it grew to maturity, but was sterile, thus evolutionarily “dead”. So perhaps this 
sterility is a potential phenotype for worms homozygous for arx-3. 
 
Strain/Cross Name Plate 
Number 
Eggs? Egg 
Count 
Worm 
Count 
Percent 
Worms 
flp-20;csn-5 X self      (Progeny) 1 YES x X  
flp-20;csn-5 X self      (Progeny) 2 YES x X  
flp-20;csn-5 X self      (Progeny) 3 YES x X  
flp-20;csn-5 X self      (Progeny) 4* YES x X  
flp-20;csn-5 X self      (Progeny) 5 YES x X  
flp-20;csn-5 X self      (Progeny) 6 YES x X  
flp-20;csn-5 X self      (Progeny) 7 YES x X  
flp-20;csn-5 X self      (Progeny) 8 YES x X  
flp-20;csn-5 X self      (Progeny) 9* YES x X  
flp-20;csn-5 X self      (Progeny) 10 YES x X  
      
flp-20;arx-3 X self      (Progeny) 1* YES 62 21 34% 
flp-20;arx-3 X self      (Progeny) 2 YES 2   
flp-20;arx-3 X self      (Progeny) 3 YES 16 7 44% 
flp-20;arx-3 X self      (Progeny) 4 YES 111 99 89% 
flp-20;arx-3 X self      (Progeny) 5* YES 84 30 36% 
flp-20;arx-3 X self      (Progeny) 6 YES 37 18 49% 
flp-20;arx-3 X self      (Progeny) 7 YES 142 113 80% 
flp-20;arx-3 X self      (Progeny) 8 YES 75 32 43% 
flp-20;arx-3 X self      (Progeny) 9 YES    
flp-20;arx-3 X self      (Progeny) 10 YES 60 28 47% 
flp-20;arx-3 X self      (Progeny) 11 YES 116 46 40% 
flp-20;arx-3 X self      (Progeny) 12 YES 70 28 40% 
      
csn-5 (Parent Strain) 1 YES x X  
csn-5 (Parent Strain) 2 YES x X  
arx-3 (Parent Strain) 1 YES 77 22 28% 
arx-3 (Parent Strain) 2 YES 34 10 29% 
Table 5. Strain Verification Experiment for C. elegans Strains Possessing Marked Migratory Neurons. *These 
plates were maintained and were used in quantitation experiments. The ‘Strain/Cross Name’ column is not the real 
genotype of the strain, but rather a shorthand for the mutant/balancer strain produced. 
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This table shows the singled L4s and the egg/worm counts to objectively determine 
survival rates for the arx-3 worms (RY 1163). The plates of csn-5 worms (RY 1161) were 
scanned for vulval masses, but were not counted. The plate numbers marked with an asterisk 
were believed to be the sought after strains and were maintained and used in quantitation 
experiments. The csn-5 plate chosen had the most obvious and highest incidence of worms 
exhibiting vulval masses (subjective determination) because this is the phenotype of worms 
homozygous for csn-5 (ok 1064). The arx-3 plate chosen had the lowest survival rate, which 
most closely resembled that of the parent strain where worms homozygous for arx-3 (ok 1122) 
are thought to die early in development. 
 
These counting experiments were performed in order to distinguish between balancer/mutant and 
balancer / + in the last step of each cross.  This was done because both arx-3 and the balancer 
used increase lethality, so the desired strain of arx-3 / balancer was distinguished from 
+/balancer by looking for animals with fewer progeny.   
 
Ten worm PCRs are currently underway to further confirm that the generated strains for 
ARX-3 (RY 1162 and RY 1163) and CSN-5 (RY 1160 and RY 1161) are correct. PCR samples 
are being run on 0.8% acrylamide gels and band sizes are being compared to those of the parent 
strains. Each strain is currently being quantitated in order to study mutant phenotypes which may 
indicate an in vivo interaction. Some preliminary photos of mutant pgp-12 C. elegans strains as 
compared to wild type are shown below, no obvious excretory cell phenotypes have been seen. 
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Figure 13. Mutant Transgenic C. elegans Strains (a) CSN-5; pgp-12, (b) WT pgp-12 and (c) ARX-3; pgp-12. A 
sampling of photos being used to quantitate the excretory cell truncation phenotypes of the RY 1162 and RY 1161 
C. elegans strains as compared to wild type worms. 
(c) 
(b) (a) 
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Discussion 
 
The overall goal for this Major Qualifying Project (MQP) was to determine whether 
ARX-3, an Arp2/3 subunit or CSN-5, a COP-9 SigNalosome subunit, interact with MIG-10 to 
promote axon outgrowth and migration. The MIG-10/subunit interaction was previously 
identified using a yeast two hybrid system (Gosselin and O’Toole, 2008). This MQP further 
confirms the MIG-10/subunit interaction in vitro, by using an insect cell expression system, and 
in vivo, using mutant transgenic C. elegans strains. Preliminary results indicate interaction in 
vitro between MIG-10 and both proteins. In vivo experiments are ongoing.  
 
The preliminary result that ARX-3 and CSN-5 interact with MIG-10 to promote neuronal 
outgrowth and migration does support the findings of a prior MQP where a yeast-two hybrid 
assay suggested both interactions, but there is insufficient data to confidently confirm the 
interaction as there was only one successful repetition of each protein specific co-
immunoprecipitation experiment whereas three repetitions of each would have been significant. 
In addition, the “successful” experiments yielded weak bands at high exposure times, while 
darker bands at lower exposure times would have been more desirable. These results were most 
likely due to technical difficulties with the assays (cell health, wash stringency, incubation times 
etc.), so ultimately, these experiments should be continued and repeated for more definite results.  
 
There are many aspects of the techniques used in this project that should be noted or 
changed when experiments are repeated in the future. First, when performing cloning 
experiments, care should be taken to use antibiotic dosage experiments in the event of difficulties 
 46 | P a g e  
 
with plasmid uptake and production as higher antibiotic dosage was found to remedy the 
problem.  Secondly, when co-immunoprecipitation experiments are repeated, special attention 
should be paid to the health quality of the D. melanogaster S3 cells. Over the course of this 
project the S3 cells deteriorated in condition from fast growing with a round morphology to slow 
growing displaying a branched morphology. The first two out of six co-immunoprecipitation 
experiments yielded interpretable results while the last four yielded no reliable results. This was 
likely due to suboptimal DNA uptake at transfection due to deteriorated health. An investigation 
into cell culture techniques, perhaps using conditioned media or reducing splitting ratios 
temporarily, may remedy this problem in the long run. Lastly, co-immunoprecipitations could be 
improved through alterations in antibody/bead incubation times by lengthening the incubation 
times, and alterations in the salinity or pH of washes and buffers in order to reduce their 
stringency. 
 
The in vivo C.elegans experiments are ongoing and the mutant strains do appear to be 
correct, but PCR confirmation and a larger quantitation sample size is required before any 
remarks can be made about the in vivo interaction of ARX-3 and CSN-5 with MIG-10. Through 
subjective observation, the csn-5::pgp-12:GFP strain does appear to have a very slight excretory 
cell truncation while the arx-3::pgp-12:GFP strain appears to demonstrate wild type excretory 
cells. However, the worms that can be observed as the L4 stage in the arx-3 strain are likely 
heterozyogotes, since the arx-3 mutation is thought to be embryonic lethal. 
 
In the future, the csn-5 strain quantitation will continue at the L4 stage as usual but it 
should be advised to quantitate the arx-3 strains as egg preps so that the embryonic phenotype 
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can be measured before the lethality of the mutation takes effect. Also, the strains should be 
frozen down for future use after a sample of each undergoes PCR and perhaps sequencing 
analysis in order to confirm and preserve the strains for future research. 
 
This interaction or lack thereof should be confirmed in the future, and if such an 
interaction was to be confirmed with significant data, then an effort should be made in order to 
investigate any potential interaction domains of ARX-3 and CSN-5 that interact with the various 
domains of MIG-10. This could be achieved by creating deletion mutants of both ARX-3 and 
CSN-5 and performing pull down experiments first with the deletion mutants and MIG-10a, and 
then with the confirmed domain of the candidate proteins with stock deletion mutants of MIG-
10a. This way more detail can be understood of the signaling cascade which promotes neuronal 
outgrowth and migration, and can help researchers better understand MIG-10 orthologs, like 
lamellipodin, and vertebrate ARX-3 and CSN-5 proteins and how they interact in the vertebrate 
neuronal guidance system during development. This research could ultimately lead to a much 
better understanding of many neurodevelopmental disorders such as autism and Down’s 
syndrome. Understanding the processes responsible for neuronal connectivity would not only 
help elucidate the causes of neurodevelopmental disorders, but could also provide various new or 
improved treatment options for individuals with nerve damage due to injury such as a traumatic 
brain injury, or neurodegenerative disorders such as Alzheimer’s disease. 
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Recipe Appendix 
 
For Protein Gels and Westerns 
 
Stock Solutions: 
 
2M Tris-HCl (pH 8.8; adjust with HCl and autoclave) 
1M Tris-HCl (pH 6.8; adjust with HCl and autoclave) 
10% SDS 
1% bromophenol blue (dissolve as completely as possible, centrifuge and keep supernatant) 
 
Working Solutions (all should be kept at 4C unless stated otherwise): 
 
Solution A (acrylamide mix)  [100 mL]: 
29.2% acrylamide  [29.2 g] 
0.8% bis-acrylamide  [0.8 g] 
 
Solution B (4X separating gel buffer) [50 mL]: 
1.5M Tris-HCl (pH 8.8)   [37.5 mL 2M] 
0.4% SDS    [2 mL 10%] 
dH2O     [10.5 mL] 
 
Solution C (4X stacking gel buffer) [50 mL]: 
0.5M Tris-HCl (pH 6.8)   [25 mL 1M] 
0.4% SDS    [2 mL 10%] 
dH2O     [23 mL] 
 
10% APS (-20)[1 mL]: 
10% APS [0.1g] 
dH2O  [1 mL] 
 
5X Sample Buffer  [5 mL; then make 1mL aliquots]: 
60mM Tris-HCl (pH 6.8) [0.3 mL 1M] 
25% glycerol   [1.25 mL 100%] 
2% SDS   [1 mL 10%] 
14.4mM -mercaptoethanol [0.25 mL] 
0.1% bromphenol blue  [0.5 mL 1%] 
dH2O    [1.7 mL] 
 
10X Electrophoresis Buffer (RT) [1 L]: 
250mM Tris    [30 g] 
1.92M glycine    [144 g] 
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1% w/v SDS    [10 g] 
dH2O     [to 1 L] 
 
20X Transfer Buffer (RT) [1 L] 
312mM Tris   [38.6 g] 
2.4M glycine   [180 g] 
dH2O     [to 1 L] 
 
Separating Gel (at least 5mL per gel) 
 5 mL 10 mL 15 mL 20 mL 
dH2O 2.42 4.84 7.26 9.68 
Solution A 1.33 2.66 3.99 5.32 
Solution B 1.25 2.5 3.75 5 
10% APS 0.025 0.05 0.075 0.1 
TEMED 0.0025 0.005 0.0075 0.01 
 
Stacking Gel (5 mL per 2 gels) 
 5 mL 10 mL 
dH2O 2.3 4.6 
Solution A 0.67 1.34 
Solution C 1 2 
10% APS 0.03 0.06 
TEMED 0.005 0.01 
 
For Co-Immunoprecipitations 
 
EBC Buffer (aka NP-40 Buffer):  
50 mM Tris, pH 8  
150 mM NaCl 
2 mM EDTA 
0.5% NP-40 
 
Buffer X: 
50 mM Tris, pH 8.5 
250 mM NaCl 
2 mM EDTA 
1% NP-40 
 
Final Wash Buffer:  
50 mM Tris, pH 8.5 
 
Protease inhibitor cocktail: 
Dissolve 1 Roche Complete EDTA-free protease inhibitor cocktail tablet in 2 mL dH2O 
to produce a 25X stock. Aliquot and store at -20°C.   
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Phosphatase inhibitor cocktail:  Stock [C]    Solvent 
1 mM Sodium orthovanadate               200 mM  dH2O 
5 mM Sodium pyrophosphate                100 mM  dH2O 
5 mM Sodium fluoride                                   100 mM            dH2O 
